Cargando…

Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity

Tumor plasticity refers to tumor cell's inherent property of transforming one type of cell to different types of cells. Tumor plasticity is the main cause of tumor relapse, metastasis and drug resistance. Cancer stem cell (CSC) model embodies the trait of tumor plasticity. During carcinoma prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiao-Guang, Zhu, Lan-Cao, Wang, Yan-Jun, Li, Yan-Yu, Wang, Dun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746935/ https://www.ncbi.nlm.nih.gov/pubmed/31552191 http://dx.doi.org/10.3389/fonc.2019.00887

Ejemplares similares

SMC4, a novel tumor prognostic marker and potential tumor therapeutic target
por: Zhao, Zonglei, et al.
Publicado: (2023)

SPINKs in Tumors: Potential Therapeutic Targets
por: Liao, Chengcheng, et al.
Publicado: (2022)

Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
por: Padfield, Emily, et al.
Publicado: (2015)

Emerging Applications of Deep Learning in Bone Tumors: Current Advances and Challenges
por: Zhou, Xiaowen, et al.
Publicado: (2022)

Editorial: Anakoinosis for promoting tumor tissue editing: Novel therapeutic opportunities for establishing clinically relevant tumor control by targeting tumor plasticity
por: Heudobler, Daniel, et al.
Publicado: (2022)

ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
por: Wei, Yaolu, et al.
Publicado: (2022)

Therapeutic potential of vasculogenic mimicry in urological tumors
por: Lin, Xinyu, et al.
Publicado: (2023)

Semaphorins as Potential Immune Therapeutic Targets for Cancer
por: Jiang, Jun, et al.
Publicado: (2022)

Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma
por: Dong, Tianyu, et al.
Publicado: (2022)

Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic Optimization
por: Fanelli, Giuseppe Nicolò, et al.
Publicado: (2020)

Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer
por: Wang, Li-ting, et al.
Publicado: (2022)

Editorial: Understanding mitochondrial dynamics and metabolic plasticity in cancer stem cells: Recent advances in cancer treatment and potential therapeutic approaches
por: Darvin, Pramod, et al.
Publicado: (2023)

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma
por: Redini, Françoise, et al.
Publicado: (2015)

Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents
por: Daniotti, Jose Luis, et al.
Publicado: (2016)

Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
por: Lin, Li, et al.
Publicado: (2023)

Proteoglycans as Therapeutic Targets in Brain Cancer
por: Yan, Zoya, et al.
Publicado: (2020)

Current Advances and Challenges in Radiomics of Brain Tumors
por: Yi, Zhenjie, et al.
Publicado: (2021)

Wheat Germ Agglutinin as a Potential Therapeutic Agent for Leukemia
por: Ryva, Bradley, et al.
Publicado: (2019)

Curcumin as a Potential Therapeutic Agent in Certain Cancer Types
por: Vadukoot, Anish K, et al.
Publicado: (2022)

Circulating Tumor DNA Is Capable of Monitoring the Therapeutic Response and Resistance in Advanced Colorectal Cancer Patients Undergoing Combined Target and Chemotherapy
por: Cao, Hua, et al.
Publicado: (2020)

Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment
por: Zhang, Jiaxin, et al.
Publicado: (2022)

The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target
por: Gao, Dacheng, et al.
Publicado: (2022)

Targeting TMEM88 as an Attractive Therapeutic Strategy in Malignant Tumors
por: Cai, Ming, et al.
Publicado: (2022)

Emerging roles of platelets in cancer biology and their potential as therapeutic targets
por: Wang, Lei, et al.
Publicado: (2022)

Advances in the Study of CircRNAs in Tumor Drug Resistance
por: Wang, Song, et al.
Publicado: (2022)

CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
por: Schettini, Francesco, et al.
Publicado: (2018)

Advances in hyperbaric oxygen to promote immunotherapy through modulation of the tumor microenvironment
por: Wang, Pei, et al.
Publicado: (2023)

Glucose Metabolism on Tumor Plasticity, Diagnosis, and Treatment
por: Lin, Xiaoping, et al.
Publicado: (2020)

Identification of Potential Therapeutic Targets and Immune Cell Infiltration Characteristics in Osteosarcoma Using Bioinformatics Strategy
por: Niu, Jianfang, et al.
Publicado: (2020)

Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis
por: Wang, Chuqi, et al.
Publicado: (2022)

Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities
por: Kalyanaraman, Balaraman, et al.
Publicado: (2022)

The Hippo pathway in endometrial cancer: a potential therapeutic target?
por: Shen, Xinyun, et al.
Publicado: (2023)

The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance
por: Li, Run-Ze, et al.
Publicado: (2022)

Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress
por: Wang, Yaning, et al.
Publicado: (2021)

The role of lipid metabolism in tumor immune microenvironment and potential therapeutic strategies
por: Wang, Danting, et al.
Publicado: (2022)

Exploring the therapeutic potential of targeting polycomb repressive complex 2 in lung cancer
por: Gao, Min, et al.
Publicado: (2023)

PPAR-α Modulators as Current and Potential Cancer Treatments
por: Tan, Yan, et al.
Publicado: (2021)

Neutrophils in pancreatic cancer: Potential therapeutic targets
por: Jiang, Wenkai, et al.
Publicado: (2022)

Berberine as a potential agent for breast cancer therapy
por: Zhong, Xiao-Dan, et al.
Publicado: (2022)

Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets
por: He, Zehua, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2tvp6cr4hi6uqtdijgcv9veon7